CLINICAL_TRIALS
trial_result
· 2024-05-30
Clinical Trial Update: Safety and Efficacy of Double Staining With Brilliant Blue G for Macular Surgery [Phase 3]
Summary
Phase 3 trial assessing the safety and efficacy of double staining with Brilliant Blue G for macular surgery was terminated, involving patients with macular hol…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Asociación para Evitar la Ceguera en México | Conditions: Macular Hole, Epiretinal Membrane | Phase 3 | Status: TERMINATED